Midterm Results of Transaxillary Occluder Device Closure of Perimembranous Ventricular Septal Defect Guided Solely by Transesophageal Echocardiography

  • Weijie Liang Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Sijie Zhou Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Taibin Fan Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Shub Song Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Bin Li Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Haoj Dong Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Linhon Zhang Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Manma Hu Children’s Heart Center, People’s Hospital of Zhengzhou University, Zhengzhou, China
  • Lin Liu Department of Ultra-sound, People’s Hospital of Zhengzhou University, Zhengzhou, China

Abstract

Background: Perimembranous ventricular septal defect (pmVSD) is a common congenital heart disease. Transaxillary occluder device closure of the pmVSD has been proved effective and an alternative to surgical closure. The study aimed to evaluate the immediate operation outcomes and the early and midterm follow-up outcomes of transaxillary occluder device closure.

Methods: From January 2014 to December 2017, we retrospectively analyzed the patients who underwent transaxillary device closure of the pmVSD. All patients underwent transthoracic echocardiography (TTE), chest x-ray, and electrocardiogram (ECG) before and after the procedure (before discharging). Follow-up evaluation was completed at the time of 3, 6, 12 months and yearly thereafter in outpatient setting with TTE and ECG.

Results: A total of 428 patients (216 male, 212 female) underwent transaxillary occluder device closure of the pmVSD under the guidance of transesophageal echocardiography (TEE). The mean age at the operation time was 2.2 ± 1.5 year (range 0.5-16.2 year). The mean weight was 8.5 ± 4.1 kg (range 6-61 kg). The mean size of the occluder implanted in the operation was 5.3 ± 1.4 (range 4-8 mm), matching the mean defect size of 4.2 ± 1.1 (range 3-6 mm). The device closure operation was successfully achieved in 422 pmVSD patients (98.6%), and 6 patients failed in occluding and were converted to open surgery because of a great residual shunt and obvious device-related aortic regurgitation . Immediate complete closure was detected by postoperative TEE in all, but 3 patients had trivial residual shunting. Total early adverse events emerged in 47 patients (11.1%). New mild tricuspid and aortic regurgitation occurred in 17 and 3 patients and disappeared in follow-up. Abnormal atrioventricular conduction events emerged in 23 patients, including left anterior block, complete right bundle branch block (CRBBB), incomplete right bundle branch block (IRBBB), administrated with close follow-up. Pericardial effusion occurred in 2 other patients, managed with puncture drainage. During a median follow-up period of 26.8 months (range 6-48 months), no serious adverse event and later-on complete atrioventricular block were encountered.

Conclusion: In our experience, transaxillary device closure was performed via right infra-axillary mini-incision (invisible) guided by TEE, with low incidence of postoperative adverse events, confirming that transaxillary device closure of the pmVSD under the guidance of TEE is an effective alternative to surgical closure in well-selected pmVSD patients.

References

Bai Y, Xu XD, Li CY, et al. 2015. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: a single-center experience on 1046 cases. Heart Rhythm 12(10):2132-40.

Bouma BJ, Mulder BJ. 2017. Changing landscape of congenital heart disease. Circ Res 120(6):908-22.

Hufnagel CA, Conrad PW. 1965. Transaortic repair of ventricular septal defects. Am J Surg 110:448-51.

Hong ZN, Chen Q, Lin ZW, et al. 2018. Surgical repair via submammary thoracotomy, right axillary thoracotomy and median sternotomy for ventricular septal defects. J Cardiothorac Surg 13(1):47.

Ghosh S, Sridhar A, Sivaprakasam M. 2018. Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II. Catheter Cardiovasc Interv 92(5):921-4.

Green L, Oakley CM, Davies DM, Cleland WP. 1965. Successful repair of left ventricular aneurysm and ventricular septal defect after indirect injury. Lancet 2(7420):984-6.

Karaçelik M, Öztürk P, Doyurgan O, et al. 2015. A complication following the transcatheter closure of a muscular ventricular septal defect. J Tehran Heart Cent 10(3):149-51.

Narin N, Pamukcu O, Tuncay A, et al. 2018. Percutaneous ventricular septal defect closure in patients under 1 year of age. Pediatr Cardiol 39(5):1009-15.

Ou-Yang WB, Li SJ, Wang SZ, et al. 2015. Echocardiographic guided closure of perimembranous ventricular septal defects. Ann Thorac Surg 100(4):1398-402.

Patel NH, Madan TH, Panchal AM, Thakkar BM. 2009. Percutaneous closure of patent ductus arteriosus via internal jugular vein in patient with interrupted inferior vena cava. Ann Pediatr Cardiol 2(2):162-4.

Polat TB, Türkmen E. 2016. Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience. Postepy Kardiol Interwencyjnej 12(4):340-7.

Song S, Fan T, Li B, et al. 2017. Minimally invasive peratrial device closure of perimembranous ventricular septal defect through a right infraaxillary route: clinical experience and preliminary results. Ann Thorac Surg 103(1):199-204.

Song X, Xing Q, Wu Q, Ren Y, Wan H, Li J. 2017. Transthoracic device closure of juxtaarterial ventricular septal defects: midterm follow-up results. Ann Thorac Surg 104(3):841-6.

Xing Q, Pan S, An Q, et al. 2010. Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: multicenter experience and mid-term follow-up. J Thorac Cardiovasc Surg 139(6):1409-15.

Xing Q, Wu Q, Shi L, Xing Y, Yu G. 2015. Minimally invasive transthoracic device closure of isolated ventricular septal defects without cardiopulmonary bypass: long-term follow-up results. J Thorac Cardiovasc Surg 149(1):257-64.

Xing QS, Pan SL, Zhuang ZY, et al. 2009. Minimally invasive perventricular device closure of an isolated perimembranous ventricular septal defect with a newly designed delivery system: preliminary experience. J Thorac Cardiovasc Surg 137(3):556-559.

Published
2019-03-08
How to Cite
Liang, W., Zhou, S., Fan, T., Song, S., Li, B., Dong, H., Zhang, L., Hu, M., & Liu, L. (2019). Midterm Results of Transaxillary Occluder Device Closure of Perimembranous Ventricular Septal Defect Guided Solely by Transesophageal Echocardiography. The Heart Surgery Forum, 22(2), E112-E118. https://doi.org/10.1532/hsf.2185
Section
Articles